The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: a randomized crossover clinical trial.
about
A Multi-scale Computational Platform to Mechanistically Assess the Effect of Genetic Variation on Drug Responses in Human Erythrocyte MetabolismRoles of functional catechol-O-methyltransferase genotypes in Chinese patients with Parkinson's disease.COMT Val158Met Polymorphism Modulates Huntington's Disease Progression.The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism.Putative cortical dopamine levels affect cortical recruitment during planning.Pharmacogenetics of Parkinson's disease - through mechanisms of drug actions.Pharmacological treatment and the prospect of pharmacogenetics in Parkinson's disease.Pharmacogenomics in neurology: current state and future steps.Anti-Parkinson's disease drugs and pharmacogenetic considerations.Parkinson's disease pharmacogenomics: new findings and perspectives.Pharmacogenetics of drug response in Parkinson's disease.Pharmacogenetic considerations in the treatment of Parkinson's disease.How close are we to individualized medicine for Parkinson's disease?Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson's disease: a pharmacogenetic study.A neurological perspective on the enhancement debate: Lessons learned from Parkinson's disease.Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease.A systematic review and integrative approach to decode the common molecular link between levodopa response and Parkinson's diseaseAssociation Between Catechol-O-Methyltransferase (COMT) Gene Polymorphisms, Parkinson's Disease, and Levodopa Efficacy.Association between maternal COMT gene polymorphisms and fetal neural tube defects risk in a Chinese population.Genetics and Treatment Response in Parkinson's Disease: An Update on Pharmacogenetic Studies.Adverse effects produced by different drugs used in the treatment of Parkinson's disease: A mixed treatment comparison.Levodopa-entacapone-carbidopa intestinal gel in Parkinson's disease: A randomized crossover study.
P2860
Q28553224-F1498872-3D40-4A93-A9E4-5426A8807BAAQ33604514-8DC8C719-AB38-441F-A66D-B9D98F724219Q36140827-BFA6440D-B827-4EE3-9429-4BC982CC865AQ36822049-F0F7D053-0E67-4B8E-BA24-FF2FDFD2B02EQ37254819-1689F689-9AE5-4B51-87E4-83F7C6CA3D32Q37583417-9C61AC40-27DE-4E48-B1A5-5A5B84A543F2Q37957393-906B51CB-8550-4A89-B7FA-52A2825E26C9Q37967607-23490B1A-DC40-433D-9C66-AAB45F9AD968Q38097097-4CFEF40C-8B49-408F-BF7F-A23D1D692A91Q38241678-71C70F69-5175-40DB-888A-41D379594E2EQ38250117-B9C34B89-4F3E-4BA0-A528-8D419644891BQ38364825-09A004F5-1001-4B3B-98D2-4B67253323DEQ38814888-F7D39196-EBAA-45C6-9259-EC02FFEF7BAEQ38865983-7BBBEA0C-563C-4B5A-B17E-2CBA7FAE29C5Q38948788-17944924-323F-481E-A033-210E76EE7D2AQ41168222-276B1636-1E6C-401D-A796-71476F09938CQ41711967-1A030E2A-33F4-4D06-A89B-A91BFBFDF1BDQ43662733-50385EE5-9F8D-4503-BAFC-EF7404D48622Q44990623-2FD90990-6191-480D-B811-0DB3E117C6F2Q47648607-EEFFBE3B-1219-4B2C-85D0-A42DFD23C07BQ48129862-4F49974B-FD40-4139-9052-4FFDAD58690CQ48721847-B2249278-8376-42B9-BCC9-CA35AAA0BA46
P2860
The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: a randomized crossover clinical trial.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
The COMT Val158Met polymorphis ...... ized crossover clinical trial.
@en
The COMT Val158Met polymorphis ...... ized crossover clinical trial.
@nl
type
label
The COMT Val158Met polymorphis ...... ized crossover clinical trial.
@en
The COMT Val158Met polymorphis ...... ized crossover clinical trial.
@nl
prefLabel
The COMT Val158Met polymorphis ...... ized crossover clinical trial.
@en
The COMT Val158Met polymorphis ...... ized crossover clinical trial.
@nl
P2093
P2860
P50
P356
P1433
P1476
The COMT Val158Met polymorphis ...... ized crossover clinical trial.
@en
P2093
Agnès Bellanger
Andreas Hartmann
Anne-Marie Bonnet
Cécilia Bonnet
Cédric Vrignaud
Emmanuel Roze
Fanny Charbonnier-Beaupel
Gayané Meliksetyan
Jean Costentin
Lucette Lacomblez
P2860
P304
P356
10.1002/ANA.22155
P577
2011-01-01T00:00:00Z